Hu, Y., Tan, Q. S., Zhang, M., Wei, G., Cui, J., Tan, B., Li, D., Xiang, Y., Du, B., Liu, M., Huang, H. (2026). Allogeneic CD19-targeted CAR-T therapy (BRL-301) for relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14518